Media Room Menu
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Dec 20, 2006Record production capabilities strengthen sanofi pasteur’s global leadership in the fight against seasonal influenza and place the company at the forefront of pandemic readiness
-
Dec 12, 2006The PREVAIL study showed that in acute ischemic stroke patients treated with Lovenox, the risk of having a VTE was lowered by a significant 43% with no statistically significant increase in clinically important bleedings when compared to UFH
-
Dec 8, 2006
-
Dec 5, 2006First Rimonabant Trial with HbA1c as a Primary Endpoint
-
Nov 27, 2006Sanofi pasteur able to produce additional vaccine to meet customer demand
-
Nov 20, 2006New pre-pandemic vaccine will provide additional level of preparedness
-
Oct 31, 2006Sales Growth of 2.6% on a Comparable Basis(1)
-
Oct 30, 2006Comparative Clinical Trial Results Announced for the Treatment of Nasolabial Folds at the 2006 American Society of Dermatologic Surgery (ASDS) Annual Meeting
-
Oct 18, 2006Taxotere(R)-based regimen demonstrates a significantly longer progression free survival and 29 percent reduction in the risk of mortality in patients with inoperable locally advanced head and neck cancer
-
Oct 18, 2006New formulation provides non-impairing symptom relief for pediatric populations
-
Oct 12, 2006As communicated by CDC, majority of supply will be available in October and November; sanofi pasteur shipped one-third of influenza vaccine planned for 2006-2007 season
-
Sep 26, 2006Flu vaccine based on new technology within U.S. Government Preparedness Program
-
Sep 1, 2006Shipment of Fluzone Influenza Virus Vaccine to U.S. Market Begins
-
Aug 17, 2006Expands PLAVIX Indication to include patients with any acute coronary syndromes (ACS)
-
Aug 14, 200612 Million Men in U.S. at Risk for this Fragile Bone Disease
-
Jul 12, 2006Results extending the role of AMBIEN CR in the treatment of insomnia presented at the 2006 CINP (Collegium Internationale Neuro-Psychopharmacologicum) 25th Biennial Congress
-
Jul 3, 2006Complications from DVT kill up to 200,000 Americans every year, yet the risk of DVT can be reduced